- Joined
- May 9, 2005
- Messages
- 162
- Reaction score
- 3
Came across your comments on FDA regulation of pain devices vis a vis the ISIS forum...your comments are prescient...
the FDA has delayed approval of the vagal nerve stimulator for depression, due to lack of sufficient data, ie., RCTs..., note that they did not delay approval based on safety data alone, but rather, lack of clinical outcomes data...the sad part is that the VNS probably works in those patients who have exhausted all other treatments and it is a pretty easy and safe procedure for a neurosurgeon....go figure
I don't understand how most of our interventional pain devices escaped the FDA clinical data radar?
IDET was FDA approved even before there was significant peer reviewed published (not abstracts) animal/cadaver data and human clinical data...then again, most of the devices in pain use existing technologies and may be they are getting away with investigational device exemptions?
Any thoughts?
the FDA has delayed approval of the vagal nerve stimulator for depression, due to lack of sufficient data, ie., RCTs..., note that they did not delay approval based on safety data alone, but rather, lack of clinical outcomes data...the sad part is that the VNS probably works in those patients who have exhausted all other treatments and it is a pretty easy and safe procedure for a neurosurgeon....go figure
I don't understand how most of our interventional pain devices escaped the FDA clinical data radar?
IDET was FDA approved even before there was significant peer reviewed published (not abstracts) animal/cadaver data and human clinical data...then again, most of the devices in pain use existing technologies and may be they are getting away with investigational device exemptions?
Any thoughts?